Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Procedure-Related Readmission and Evolving Trends in Transurethral Prostate Surgery for Benign Prostatic Obstruction: A Two-Decade Paradigm Shift

View through CrossRef
Abstract Background and Objective: Transurethral prostatic surgery (TUPS) has been evolving throughout the past 20 years which impacts procedure related readmissions (PRR). Long-term data about PRR across different techniques are limited. We aim at reporting causes, predictors, and rates of PRR over two decades. Methods: A prospectively maintained prostate database was reviewed for TUPS performed between January 2005 to December 2024 in a tertiary referral center. PRR was reported across 4 consecutive time-periods and across 4 distinct TUPS techniques, namely incision (TUIP), resection (TURP), vaporization and enucleation (AEEP). Regression analysis was used to define predictors of PRR over different time-periods. Key Findings and Limitations: Overall PRR rate was 8.3% (663/8031) at median follow-up of 60 months: 12.9, 8.2, 13.8 and 5.8% following TUIP, TURP, vaporization and AEEP respectively. A 5-year overall PRR-free survival was highest 93.8% (CI 92.6–95.0) in the AEEP group and lowest 84.5% (CI 81.0–88.0) in the vaporization group (P < 0.001). Independent predictors of PRR included older age (OR 1.08 per year), higher BMI (OR 1.04), high ASA score ≥3 (OR 7.87), procedure type (vs. AEEP: TUIP OR 2.79, TURP OR 2.37, vaporization OR 2.71), hematuria at presentation (OR 1.54), and surgeon experience <5 years (OR 1.35). TURP decreased, enucleation increased; regrown adenoma PRR fell, while PPI rose over time. Limitations: retrospective design, potential selection bias, and limited generalizability. Interventions : transurethral incision, resection, vaporization, and AEEP. Conclusions: The lowest PRR was observed following AEEP. Modifiable risk factors for PRR were the surgical technique and the surgeon’s experience.
Title: Procedure-Related Readmission and Evolving Trends in Transurethral Prostate Surgery for Benign Prostatic Obstruction: A Two-Decade Paradigm Shift
Description:
Abstract Background and Objective: Transurethral prostatic surgery (TUPS) has been evolving throughout the past 20 years which impacts procedure related readmissions (PRR).
Long-term data about PRR across different techniques are limited.
We aim at reporting causes, predictors, and rates of PRR over two decades.
Methods: A prospectively maintained prostate database was reviewed for TUPS performed between January 2005 to December 2024 in a tertiary referral center.
PRR was reported across 4 consecutive time-periods and across 4 distinct TUPS techniques, namely incision (TUIP), resection (TURP), vaporization and enucleation (AEEP).
Regression analysis was used to define predictors of PRR over different time-periods.
Key Findings and Limitations: Overall PRR rate was 8.
3% (663/8031) at median follow-up of 60 months: 12.
9, 8.
2, 13.
8 and 5.
8% following TUIP, TURP, vaporization and AEEP respectively.
A 5-year overall PRR-free survival was highest 93.
8% (CI 92.
6–95.
0) in the AEEP group and lowest 84.
5% (CI 81.
0–88.
0) in the vaporization group (P < 0.
001).
Independent predictors of PRR included older age (OR 1.
08 per year), higher BMI (OR 1.
04), high ASA score ≥3 (OR 7.
87), procedure type (vs.
AEEP: TUIP OR 2.
79, TURP OR 2.
37, vaporization OR 2.
71), hematuria at presentation (OR 1.
54), and surgeon experience <5 years (OR 1.
35).
TURP decreased, enucleation increased; regrown adenoma PRR fell, while PPI rose over time.
Limitations: retrospective design, potential selection bias, and limited generalizability.
Interventions : transurethral incision, resection, vaporization, and AEEP.
Conclusions: The lowest PRR was observed following AEEP.
Modifiable risk factors for PRR were the surgical technique and the surgeon’s experience.

Related Results

Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Prostatic artery embolization as a method for prevention of infravesical obstruction after low-dose-rate brachytherapy
Prostatic artery embolization as a method for prevention of infravesical obstruction after low-dose-rate brachytherapy
BACKGROUND: Infravesical obstruction in patients with localized prostate cancer caused by concomitant benign prostatic hyperplasia substantially limits the feasibility of low-dose-...
Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model
Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model
Background: Benign prostatic hyperplasia [BPH] is the urologic condition that affects elderly men the most frequently Benign prostatic hyperplasia. Benign prostatic hyperplasia mus...
Monotherapy versus combination therapy in the treatment of benign prostatic hyperplasia: A single center study
Monotherapy versus combination therapy in the treatment of benign prostatic hyperplasia: A single center study
Background and objectives: Most benign prostatic hyperplasia patients do not present obvious indicators for surgical intervention, so most of these patients are treated initially w...
Prostate specific antigen in the serum of men ≥ 50 years old with benign prostatic hyperplasia and some related factors
Prostate specific antigen in the serum of men ≥ 50 years old with benign prostatic hyperplasia and some related factors
Background: Men over 50 years old often have lower urinary tract symptoms and most of them are caused by benign prostatic hyperplasia (BPH). The incidence of benign prostatic hyper...
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract The human olfactomedin 4 gene (OLFM4) encodes an olfactomedin-related glycoprotein, which our group first cloned and characterized in myeloid cells and mapp...

Back to Top